Diane M Gable, MD | |
15 Evergreen Dr, Oakland, ME 04963-5364 | |
(207) 872-0533 | |
(207) 873-3428 |
Full Name | Diane M Gable |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 15 Evergreen Dr, Oakland, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003817008 | NPI | - | NPPES |
027880 | Other | ME | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 012113 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Diane M Gable, MD 15 Evergreen Dr, Oakland, ME 04963-5364 Ph: (207) 872-0533 | Diane M Gable, MD 15 Evergreen Dr, Oakland, ME 04963-5364 Ph: (207) 872-0533 |
News Archive
PTC Therapeutics, Inc. (PTC) today announced the receipt of a $1 million Challenge Grant award from the National Heart, Lung, and Blood Institute (NHLBI) as part of the National Institutes of Health (NIH).
Patients with a single illness who take many drugs have an increased risk of being admitted to hospital, but for patients with multiple conditions, taking many medicines is now associated with a near-normal risk of admission. This is the key finding of work published in the British Journal of Clinical Pharmacology.
Research published in the September 2009 issue of the Journal of Thoracic Oncology has found that narrow-band imaging bronchoscopy increases the specificity of bronchoscopic early lung cancer detection and can serve as an alternative detection device.
A gene that controls part of the 'tick tock' in a plant's circadian clock has been identified by UC Davis researchers. And not only is the plant gene very similar to one in humans, but the human gene can work in plant cells and vice versa.
The risk of developing cervical cancer can be significantly decreased through human papillomavirus vaccination. Despite calls from leading health and professional organizations for universal vaccination for girls ages 11 and 12, the most recently published national data indicate that only 14.5 percent of 11- and 12-year-old girls have received at least one dose of the HPV vaccine and 3 percent have completed the three-dose series. A new Moffitt Cancer Center study provides insight into physician recommendations, one important factor that may contribute to these low levels of uptake.
› Verified 6 days ago